Therapy Insight: Scleritis and its relationship to systemic autoimmune disease

Nature Clinical Practice Rheumatology

Volumn 3, Issue 4, 2007, Pages 219-226

  Smith, Justine R ^a   Mackensen, Friederike ^a   Rosenbaum, James T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN FIBRIL; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE ACETATE; PREDNISONE; RITUXIMAB; TRIAMCINOLONE ACETONIDE;

AUTOIMMUNE DISEASE; CATARACT EXTRACTION; CLINICAL FEATURE; COLLAGEN DEGRADATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG RESPONSE; ECHOGRAPHY; ENZYMATIC DEGRADATION; EPISCLERITIS; FILTERING OPERATION; GASTROINTESTINAL TOXICITY; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INTRAOCULAR HYPERTENSION; IRIDOCYCLITIS; MORTALITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERFORATING EYE INJURY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SCLERITIS; SKIN ATROPHY; SLIT LAMP; SYSTEMIC THERAPY; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS; EYE SURGERY; PATHOLOGY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROGNOSIS; SCLERITIS;

EID: 34247869877     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0454     Document Type: Review

References (53)

1. Akpek EK et al. (2004) Evaluation of patients with scleritis for systemic disease. Ophthalmology 111: 501-506
2. Tuft SJ and Watson PG (1991) Progression of scleral disease. Ophthalmology 98: 467-471
3. Sainz de la Maze M et al. (1994) Severity of scleritis and episcleritis. Ophthalmology 101: 389-396
4. McGavin DD et al. (1976) Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 60: 192-226
5. Jayson MI and Jones DE (1971) Scleritis and rheumatoid arthritis. Ann Rheum Dis 30: 343-347
6. Smith JL (1957) Ocular complications of rheumatic fever and rheumatoid arthritis.Am J Ophthalmol 43 (Pt 1): 575-582
7. Watson PG et al. (1968) Episcleritis and scleritis. I. Br J Ophthalmol 52: 278-279
8. Watson PG and Hayreh SS (1976) Scleritis and episcleritis. Br J Ophthalmol 60: 163-191
9. Watson PG (1980) The diagnosis and management of scleritis. Ophthalmology 87: 716-720
10. Sainz de la Maza M et al. (1994) Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology 101: 1281-1286
11. McCluskey PJ et al. (1999) Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106: 2380-2386
12. Jabs DA et al. (2000) Episcleritis and scleritis: Clinical features and treatment results. Am J Ophthalmol 130: 469-476
13. Sainz de la Maze M et al. (1995) Scleritis associated with systemic vasculitic diseases. Ophthalmology 102: 687-692
14. Hemady R et al. (1992) Six cases of scleritis associated with systemic infection. Am J Ophthalmol 114: 55-62
15. Livir-Rallatos C et al. (1998) Recurrent nodular scleritis associated with varicella zoster virus. Am J Ophthalmol 126: 594-597
16. Lee GA et al. (2002) Acanthamoeba sclerokeratitis: Treatment with systemic immunosuppression. Ophthalmology 109: 1178-1182
17. Macarol V and Fraunfelder FT (1994) Pamidronate disodium and possible ocular adverse drug reactions. Am J Ophthalmol 118: 220-224
18. Zamir E et al. (2001) Self-inflicted anterior scleritis. Ophthalmology 108: 192-195
19. O'Donoghue E et al. (1992) Surgically induced necrotising sclerokeratitis (SINS) - precipitating factors and response to treatment. Br J Ophthalmol 76: 17-21
20. Dorey SE et al. (2002) Orbital lymphoma misdiagnosed as scleritis. Ophthalmology 109: 2347-2350
21. Yap EY et al. (1992) Scleritis as an initial manifestation of choroidal malignant melanoma. Ophthalmology 99: 1693-1697
22. Soukiasian SH et al. (1992) Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology 99: 125-132
23. Hembry RM et al. (1979) Experimental model for scleritis. Arch Ophthalmol 97: 1337-1340
24. Fong LP et al. (1991) Immunopathology of scleritis. Ophthalmology 98: 472-479
25. Young RD and Watson PG (1984) Microscopical studies of necrotising scleritis. I. Cellular aspects. Br J Ophthalmol 68: 770-780
26. Rao NA et al. (1985) Necrotizing scleritis. A clinicopathologic study of 41 cases. Ophthalmology 92: 1542-1549
27. Young RD and Watson PG (1984) Microscopical studies of necrotising scleritis. II. Collagen degradation in the scleral stroma. Br J Ophthalmol 68: 781-789
28. Di Girolamo N et al. (1997) Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 150: 653-666
29. Riono WP et al. (1999) Scleritis: A clinicopathologic study of 55 cases. Ophthalmology 106: 1328-1333
30. Erhardt CC et al. (1989) Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study. Ann Rheum Dis 48: 7-13
31. Rosenbaum JT and Robertson JE Jr (1993) Recognition of posterior scleritis and its treatment with indomethacin. Retina 13: 17-21
32. Sainz de la Maze M et al. (1993) An analysis of therapeutic decision for scleritis. Ophthalmology 100: 1372-1376
33. Bauer AM et al. (2005) Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. Am J Ophthalmol 139: 1086-1089
34. Spiegel BM et al. (2005) Minimizing complications from nonsteroidal antiinflammatory drugs: Cost-effectiveness of competing strategies in varying risk groups. Arthritis Rheum 53: 185-197
35. Messmer EM and Foster CS (1995) Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea 14: 408-417
36. Kaplan-Messas A et al. (2003) Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis. Ocul Immunol Inflamm 11: 131-139
37. Shah SS et al. (1992) Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99: 1419-1423
38. Sen HN et al. (2003) Mycophenolate mofetil for the treatment of scleritis. Ophthalmology 110: 1750-1755
39. Thorne JE et al. (2005) Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112: 1472-1477
40. Hakin KN et al. (1991) Use of cyclosporin in the management of steroid dependent non-necrotising scleritis. Br J Ophthalmol 75 340-341
41. Wakefield D and McCluskey P (1989) Cyclosporin therapy for severe scleritis. Br J Ophthalmol 73: 743-746
42. Langford CA et al. (2003) Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: Extended follow-up and rate of relapse. Am J Med 114: 463-469
43. Stone JH (2002) Polyarteritis nodosa. JAMA 288: 1632-1639
44. Albini TA et al. (2005) Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology 112: 1814-1820
45. Sen HN et al. (2005) Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis. Br J Ophthalmol 89: 917-918
46. TU EY et al. (1995) Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology 102: 718-724
47. Smith JR et al. (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 45: 252-257
48. El-Shabrawi Y and Hermann J (2005) Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis. Eye 19: 1017-1018
49. Cazabon S et al. (2005) The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye 19: 222-224
50. Murphy CC et al. (2004) Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111: 352-356
51. Papaliodis GN et al. (2003) Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology 110: 786-789
52. Ahmadi-Simab K et al. (2005) Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab. Ann Rheum Dis 64: 1087-1088
53. Cheung CM et al. (2005) Successful treatment of Wegener's granulomatosis associated scleritis with rituximab. Br J Ophthalmol 89: 1542